{"result": "(\"entity\"<|>UCI<|>ORGANIZATION<|>UCI refers to the Intensive Care Unit where critical patients are treated and monitored.)\n##\n(\"entity\"<|>CLOSTRIDIUM DIFFICILE<|>ORGANIZATION<|>Clostridium difficile is a bacterium that can cause infections in the intestines, often leading to diarrhea, especially in patients receiving antibiotics.)\n##\n(\"entity\"<|>METOCLOPRAMIDA<|>ORGANIZATION<|>Metoclopramida is a medication used to treat nausea and gastroparesis, often used in critical care settings.)\n##\n(\"entity\"<|>ERITROMICINA<|>ORGANIZATION<|>Eritromicina is an antibiotic used to treat various infections, including those in critical care patients.)\n##\n(\"entity\"<|>NE<|>ORGANIZATION<|>NE refers to Nutritional Enteral feeding, a method of providing nutrition to patients who cannot eat by mouth.)\n##\n(\"entity\"<|>FÓRMULAS POLIMÉRICAS<|>ORGANIZATION<|>Fórmulas poliméricas are standard enteral nutrition formulas that are well tolerated by most critical patients.)\n##\n(\"entity\"<|>SEPSIS SEVERA<|>EVENT<|>Sepsis severa is a life-threatening condition that arises when the body's response to infection causes injury to its own tissues and organs.)\n##\n(\"entity\"<|>CÁNCER DE CABEZA Y CUELLO<|>EVENT<|>Cáncer de cabeza y cuello refers to a group of cancers that affect the tissues of the head and neck, often requiring specialized nutritional support.)\n##\n(\"entity\"<|>TRAUMATISMO CEREBRAL<|>EVENT<|>Traumatismo cerebral refers to brain injuries that can occur due to trauma, often requiring intensive medical care and nutritional support.)\n##\n(\"entity\"<|>QUEMADOS<|>EVENT<|>Quemados refers to patients who have suffered severe burns, often requiring specialized nutritional formulas for recovery.)\n##\n(\"relationship\"<|>UCI<|>NE<|>UCI utilizes Nutritional Enteral feeding to provide nutrition to critically ill patients<|>8)\n##\n(\"relationship\"<|>CLOSTRIDIUM DIFFICILE<|>NE<|>Clostridium difficile infections can complicate the use of Nutritional Enteral feeding in patients<|>7)\n##\n(\"relationship\"<|>METOCLOPRAMIDA<|>UCI<|>Metoclopramida is recommended for use in UCI to manage gastrointestinal issues in critical patients<|>6)\n##\n(\"relationship\"<|>ERITROMICINA<|>UCI<|>Eritromicina is used in UCI to treat infections that may arise in critically ill patients<|>6)\n##\n(\"relationship\"<|>FÓRMULAS POLIMÉRICAS<|>UCI<|>Fórmulas poliméricas are the standard nutrition provided in UCI for most patients<|>8)\n##\n(\"relationship\"<|>SEPSIS SEVERA<|>UCI<|>Sepsis severa is a condition frequently treated in UCI, requiring careful nutritional management<|>9)\n##\n(\"relationship\"<|>CÁNCER DE CABEZA Y CUELLO<|>UCI<|>Patients with cáncer de cabeza y cuello often require specialized care in UCI, including nutritional support<|>7)\n##\n(\"relationship\"<|>TRAUMATISMO CEREBRAL<|>UCI<|>Traumatismo cerebral patients are often treated in UCI and may require specific nutritional interventions<|>7)\n##\n(\"relationship\"<|>QUEMADOS<|>UCI<|>Quemados patients are frequently admitted to UCI for intensive care and nutritional support<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ágico, traslado fuera de la UCI, uso de bolos intermitentes.\n\n4. EVALUACIÓN DE LA ETIOLOGÍA EN CASO DE DIARREA: tipo de fórmula, modo de administración, contaminación de la NE, fármacos, etiología infecciosa incluyendo Clostridium difficile.\n\nfuera de la UCI para procedimientos y uso de bolos intermitentes26. La neumonía y la colonización bacteriana del árbol respiratorio superior se han asociado con mayor evidencia con la aspiración de secreciones orofaríngeas contaminadas que con la regurgitación y la aspiración de contenido gástrico.\n\nEn los pacientes con elevado riesgo de aspiración se recomienda la NE postpilórica (grado de recomendación moderado o alto) y el uso de agentes procinéticos como metoclopramida o eritromicina cuando sea posible7.\n\nEn todos los pacientes intubados en UCI que reciben NE se recomienda elevar el cabecero de la cama a 30-45º y lavar la cavidad oral con clorhexidina dos veces al día.\n\nEn caso de aparición de diarrea debe estudiarse la etiología y tratarse, evitando la suspensión precoz de la NE. Los factores que pueden contribuir a la aparición de la diarrea son: tipo y cantidad de fibra en la fórmula de NE, osmolaridad de la misma, modo de administración, contaminación de la NE, fármacos (antibióticos, inhibidores de la bomba de protones, procinéticos, hipoglucemiantes, antiinflamatorios no esteroideos, inhibidores selectivos de la recaptación de serotonina, laxantes, preparados que contengan sorbitol), y la etiología infecciosa incluyendo el Clostridium difficile.\n\nLa evaluación de la diarrea debería incluir: exploración abdominal, cuantificación del número de deposiciones, coprocultivo, control analítico de electrolitos y revisión de los fármacos que están siendo administrados. Se debe intentar diferenciar entre diarrea infecciosa y osmótica27.\n\nSe debe reducir la frecuencia de interrupción de la NE antes y después de las pruebas diagnósticas y de los procedimientos, para minimizar que el íleo se prolongue y para prevenir un aporte nutricional inadecuado.\n\n5.1.7. Selección de la fórmula enteral\n\n- En la mayoría de los pacientes críticos deben utilizarse fórmulas poliméricas estándar, isocalóricas o moderadamente hipercalóricas (1 a 1,5 kcal/ml), ya que suelen ser bien toleradas y no existen suficientes evidencias para apoyar el uso de fórmulas específicas.\n\n- En muchos de los pacientes críticos los requerimientos proteicos son mayores que los calóricos, por lo que en ocasiones sería recomendable suplementar las fórmulas estándar con módulos de proteínas. Los requerimientos de proteínas son difíciles de valorar en los pacientes críticos, y pueden estimarse a partir del balance nitrogenado o aplicando la fórmula de 1,2-2 g/kg/día o la ratio kcal no proteicas/g de N: 70:1-100:1 en pacientes con IMC < 30 kg/m2.\n\n- Las fórmulas enterales inmunomoduladoras (suplementadas con arginina –Arg–, Gln, ácido eicosapentanoico –EPA–, ácido docosahexanoico –DHA–, ácidos grasos omega-3 y antioxidantes como selenio, vitamina C y vitamina E) no deben utilizarse de forma rutinaria en la UCI médica, pero deben ser consideradas en pacientes perioperatorios y en pacientes con traumatismo cerebral en UCI quirúrgica. Se deben valorar especialmente en pacientes seleccionados28:\n\n  - Cirugía mayor gastrointestinal.\n  - Traumatismos abdominales.\n  - Quemados.\n  - Cáncer de cabeza y cuello.\n  - Pacientes críticos con ventilación mecánica.\n\nMúltiples metanálisis29-31 muestran una reducción del tiempo con ventilación mecánica, de morbilidad infecciosa y de la estancia hospitalaria comparada con las fórmulas de nutrición estándar, sin demostrar disminución en la mortalidad.\n\nEn el resto de pacientes de UCI existen pocas evidencias de que estas fórmulas aporten mejoría respecto a las fórmulas estándar, aumentando los costes, por lo que su uso no se justifica.\n\nEl beneficio de las fórmulas inmunomoduladoras es dosis dependiente, así que es precisa la administración de al menos un 50-60% de los requerimientos energéticos con estos preparados.\n\nEn pacientes con sepsis severa las fórmulas que contienen Arg pueden incrementar el riesgo. En diversos estudios32,33 se observó que la mortalidad era mayor que en\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}